AstraZeneca

London: A booster dose of AstraZeneca-Oxford vaccine (Covishield in India) is being tested against the beta variant of COVID-19 that first emerged in South Africa. This trial will include…

New Delhi: AstraZeneca joins other vaccines that are effective against the Delta variant. COVID-19 Vaccine AstraZeneca offers high levels of protection against the Delta variant…

New Delhi: A study by Public Health England (PHE) has found both Oxford-AstraZeneca (Covishield in India) and Pfizer vaccines to be highly effective against the COVID-19 variant first…

Madrid: Given the shortage of vaccines, especially in a populous country like India, experts have been trying to ascertain whether mixing vaccines is advisable. A study conducted in Spain…

New Delhi: India expects to secure the biggest chunk of the 60 million Astra Zeneca COVID-19 vaccine doses that the United States will share globally, two Indian government sources told…

Berlin: Germany will use AstraZeneca’s COVID-19 vaccine for general use only for over-60-year-olds, according to the government on Tuesday. The authorities restricted the younger people from…

New Delhi: India's drug regulator has allowed The AstraZeneca COVID-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, News18…

New Delhi: A committee set up by the government on Monday, allayed the fear of people that Covishield and Covaxin increase the risk of blood clotting. The committee submitted its…

Washington: The Oxford-AstraZeneca vaccine, also known as Covishield in India, was found to be 79 per cent effective in a large US trial at preventing symptomatic illness due to COVID-19.…

New Delhi: India has decided to review the hospitalisations and deaths in people who took Covishield vaccine. The step comes after at least 10 countries suspended the use of the COVID-19…